US FDA teams up with MIT (Massachusetts Institute of Technology) in post-market effort
This article was originally published in Clinica
Executive Summary
The US FDA intends to employ the advanced computerised methods now used to track infectious diseases in order to bolster its safety monitoring of medical devices and drugs.